<DOC>
	<DOCNO>NCT02562144</DOCNO>
	<brief_summary>The enrolled subject get intravenous cannulation elbow . The subject get xylocaine spray place , intervention-arm , one intravenous cannulation one elbow , intravenous cannulation place arm placebo spray place , control arm . The pain score insertion cannulation , incidence adverse event success rate degree difficulty place intravenous cannulation . The subject one place cannulation blind treatment .</brief_summary>
	<brief_title>A Clinical Trial Cutaneous Xylocaine Spray Reduce Intravenous Cannulation Pain Adults</brief_title>
	<detailed_description>The enrolled subject get intravenous cannulation elbow . The influence leave right-handedness reduced randomizing arm subject placebo group xylocaine group . The subject get xylocaine spray place , intervention-arm , one intravenous cannulation one elbow , intravenous cannulation place arm placebo spray place , control arm . The pain score insertion cannulation , incidence adverse event success rate degree difficulty place intravenous cannulation . The subject one place cannulation blind treatment .</detailed_description>
	<mesh_term>Lidocaine</mesh_term>
	<criteria>Adults ( age 18 old ) Signing informed consent paper Allergy xylocaine Pregnancy breastfeed Peripheral neuropathy Analgesics last 24 hour Skin condition ( eczema , psoriasis , infection , abrasion ) Difficulties verbal communication No intravenous access elbow possible ( eg status axillary dissection )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>